Loading
Led PALETTE, the trial that made pazopanib the first targeted drug for soft-tissue sarcoma.
Winette van der Graaf was principal investigator of PALETTE, the EORTC trial showing pazopanib improves progression-free survival in pretreated non-adipocytic soft-tissue sarcoma, leading to its approval as the first targeted therapy in the disease. She chaired the EORTC Soft Tissue and Bone Sarcoma Group and leads adolescent and young adult cancer research in the Netherlands.
Shares Sarcomas (soft tissue, bone, GIST), Small-molecule kinase inhibitors and the tag sarcoma.
Shares VEGF / VEGFR, Sarcomas (soft tissue, bone, GIST), Small-molecule kinase inhibitors and the tags sarcoma, aya.
Shares Sarcomas (soft tissue, bone, GIST) and the tags sarcoma, aya.
Shares Erasmus MC Cancer Institute and the tag eortc.
Shares Sarcomas (soft tissue, bone, GIST), Small-molecule kinase inhibitors and the tag sarcoma.
Shares Sarcomas (soft tissue, bone, GIST) and the tag sarcoma.
Shares Sarcomas (soft tissue, bone, GIST) and the tag sarcoma.
Shares Sarcomas (soft tissue, bone, GIST) and the tag sarcoma.